538 related articles for article (PubMed ID: 31341045)
1. Protein Vaccination Directs the CD4
Rattan A; Richards KA; Knowlden ZAG; Sant AJ
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341045
[TBL] [Abstract][Full Text] [Related]
2. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
3. A Novel Vaccine Strategy to Overcome Poor Immunogenicity of Avian Influenza Vaccines through Mobilization of Memory CD4 T Cells Established by Seasonal Influenza.
DiPiazza AT; Fan S; Rattan A; DeDiego ML; Chaves F; Neumann G; Kawaoka Y; Sant AJ
J Immunol; 2019 Sep; 203(6):1502-1508. PubMed ID: 31399519
[TBL] [Abstract][Full Text] [Related]
4. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination.
Kim YJ; Kim KH; Ko EJ; Kim MC; Lee YN; Jung YJ; Lee YT; Kwon YM; Song JM; Kang SM
J Virol; 2018 Oct; 92(20):. PubMed ID: 30068650
[TBL] [Abstract][Full Text] [Related]
5. Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes.
Liao HY; Wang SC; Ko YA; Lin KI; Ma C; Cheng TR; Wong CH
Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17757-17763. PubMed ID: 32669430
[TBL] [Abstract][Full Text] [Related]
6. Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
Altenburg AF; Rimmelzwaan GF; de Vries RD
Vaccine; 2015 Jan; 33(4):500-6. PubMed ID: 25498210
[TBL] [Abstract][Full Text] [Related]
7. Hemagglutinin-specific CD4
Tan S; Zhang S; Wu B; Zhao Y; Zhang W; Han M; Wu Y; Shi G; Liu Y; Yan J; Wu G; Wang H; Gao GF; Zhu F; Liu WJ
Vaccine; 2017 Oct; 35(42):5644-5652. PubMed ID: 28917539
[TBL] [Abstract][Full Text] [Related]
8. CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential.
Sant AJ; DiPiazza AT; Nayak JL; Rattan A; Richards KA
Immunol Rev; 2018 Jul; 284(1):91-105. PubMed ID: 29944766
[TBL] [Abstract][Full Text] [Related]
9. Imprinting and Editing of the Human CD4 T Cell Response to Influenza Virus.
Nelson SA; Sant AJ
Front Immunol; 2019; 10():932. PubMed ID: 31134060
[TBL] [Abstract][Full Text] [Related]
10. Intranasal Nanoparticle Vaccination Elicits a Persistent, Polyfunctional CD4 T Cell Response in the Murine Lung Specific for a Highly Conserved Influenza Virus Antigen That Is Sufficient To Mediate Protection from Influenza Virus Challenge.
Nelson SA; Dileepan T; Rasley A; Jenkins MK; Fischer NO; Sant AJ
J Virol; 2021 Jul; 95(16):e0084121. PubMed ID: 34076479
[TBL] [Abstract][Full Text] [Related]
11. Infection with seasonal influenza virus elicits CD4 T cells specific for genetically conserved epitopes that can be rapidly mobilized for protective immunity to pandemic H1N1 influenza virus.
Alam S; Sant AJ
J Virol; 2011 Dec; 85(24):13310-21. PubMed ID: 21976658
[TBL] [Abstract][Full Text] [Related]
12. Selective pre-priming of HA-specific CD4 T cells restores immunological reactivity to HA on heterosubtypic influenza infection.
Alam S; Chan C; Qiu X; Shannon I; White CL; Sant AJ; Nayak JL
PLoS One; 2017; 12(5):e0176407. PubMed ID: 28493882
[TBL] [Abstract][Full Text] [Related]
13. A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus.
Babon JA; Cruz J; Ennis FA; Yin L; Terajima M
J Virol; 2012 Sep; 86(17):9233-43. PubMed ID: 22718815
[TBL] [Abstract][Full Text] [Related]
14. Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines.
Dong W; Bhide Y; Sicca F; Meijerhof T; Guilfoyle K; Engelhardt OG; Boon L; de Haan CAM; Carnell G; Temperton N; de Vries-Idema J; Kelvin D; Huckriede A
Front Immunol; 2018; 9():2312. PubMed ID: 30356772
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
16. Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses.
Auladell M; Jia X; Hensen L; Chua B; Fox A; Nguyen THO; Doherty PC; Kedzierska K
Front Immunol; 2019; 10():1400. PubMed ID: 31312199
[TBL] [Abstract][Full Text] [Related]
17. H5N1 Vaccine-Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin Stem.
Wheatley AK; Whittle JR; Lingwood D; Kanekiyo M; Yassine HM; Ma SS; Narpala SR; Prabhakaran MS; Matus-Nicodemos RA; Bailer RT; Nabel GJ; Graham BS; Ledgerwood JE; Koup RA; McDermott AB
J Immunol; 2015 Jul; 195(2):602-10. PubMed ID: 26078272
[TBL] [Abstract][Full Text] [Related]
18. Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice.
Choi A; Bouzya B; Cortés Franco KD; Stadlbauer D; Rajabhathor A; Rouxel RN; Mainil R; Van der Wielen M; Palese P; García-Sastre A; Innis BL; Krammer F; Schotsaert M; Mallett CP; Nachbagauer R
Immunohorizons; 2019 Apr; 3(4):133-148. PubMed ID: 31032479
[TBL] [Abstract][Full Text] [Related]
19. Epitope specific T-cell responses against influenza A in a healthy population.
Savic M; Dembinski JL; Kim Y; Tunheim G; Cox RJ; Oftung F; Peters B; Mjaaland S
Immunology; 2016 Feb; 147(2):165-77. PubMed ID: 26489873
[TBL] [Abstract][Full Text] [Related]
20. The context of epitope presentation can influence functional quality of recalled influenza A virus-specific memory CD8+ T cells.
Day EB; Zeng W; Doherty PC; Jackson DC; Kedzierska K; Turner SJ
J Immunol; 2007 Aug; 179(4):2187-94. PubMed ID: 17675478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
